Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.

International journal of cancer

Liu Y, Miyoshi H, Nakamura M.
PMID: 17390371
Int J Cancer. 2007 Jun 15;120(12):2527-37. doi: 10.1002/ijc.22709.

The diagnosis and treatment of cancer or tumor at the cellular level will be greatly improved with the development of techniques that enable the delivery of analyte probes and therapeutic agents into cells and cellular compartments. Organic and inorganic...

Cite
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007;120(12):2527-37doi: 10.1002/ijc.22709.
Liu, Y., Miyoshi, H., & Nakamura, M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. International journal of cancer, 120(12), 2527-37. https://doi.org/10.1002/ijc.22709
Liu, Yiyao, et al. "Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles." International journal of cancer vol. 120,12 (2007): 2527-37. doi: https://doi.org/10.1002/ijc.22709
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007 Jun 15;120(12):2527-37. doi: 10.1002/ijc.22709. PMID: 17390371.
Copy Download .nbib Format: NLM
New pharmacologic approaches to treating diabetic retinopathy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Ryan GJ.
PMID: 17720889
Am J Health Syst Pharm. 2007 Sep 01;64(17):S15-21. doi: 10.2146/ajhp070332.

PURPOSE: The goal of treatment of diabetic retinopathy, limitations of laser photocoagulation, endpoints used in clinical studies of diabetic retinopathy treatments, and the mechanism of action, efficacy, and safety of several new and emerging therapies targeting the biochemical pathways...

Cite
Ryan GJ. New pharmacologic approaches to treating diabetic retinopathy. Am J Health Syst Pharm. 2007;64(17):S15-21doi: 10.2146/ajhp070332.
Ryan, G. J. (2007). New pharmacologic approaches to treating diabetic retinopathy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 64(17), S15-21. https://doi.org/10.2146/ajhp070332
Ryan, Gina J. "New pharmacologic approaches to treating diabetic retinopathy." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 64,17 (2007): S15-21. doi: https://doi.org/10.2146/ajhp070332
Ryan GJ. New pharmacologic approaches to treating diabetic retinopathy. Am J Health Syst Pharm. 2007 Sep 01;64(17):S15-21. doi: 10.2146/ajhp070332. PMID: 17720889.
Copy Download .nbib Format: NLM
Bioengineering of Metal-organic Frameworks for Nanomedicine.

Theranostics

Liu Y, Zhao Y, Chen X.
PMID: 31244945
Theranostics. 2019 May 18;9(11):3122-3133. doi: 10.7150/thno.31918. eCollection 2019.

Controlled structure, tunable porosity, and readily chemical functionalizability make metal-organic frameworks (MOFs) a powerful biomedical tool. Nanoscale MOF particles have been increasingly studied as drug carriers, bioimaging agents, and therapeutic agents due to their excellent physiochemical properties. In this...

Cite
Liu Y, Zhao Y, Chen X. Bioengineering of Metal-organic Frameworks for Nanomedicine. Theranostics. 2019;9(11):3122-3133doi: 10.7150/thno.31918.
Liu, Y., Zhao, Y., & Chen, X. (2019). Bioengineering of Metal-organic Frameworks for Nanomedicine. Theranostics, 9(11), 3122-3133. https://doi.org/10.7150/thno.31918
Liu, Yuan, et al. "Bioengineering of Metal-organic Frameworks for Nanomedicine." Theranostics vol. 9,11 (2019): 3122-3133. doi: https://doi.org/10.7150/thno.31918
Liu Y, Zhao Y, Chen X. Bioengineering of Metal-organic Frameworks for Nanomedicine. Theranostics. 2019 May 18;9(11):3122-3133. doi: 10.7150/thno.31918. eCollection 2019. PMID: 31244945; PMCID: PMC6567971.
Copy Download .nbib Format: NLM
Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?.

Trends in biotechnology

Lussier F, Staufer O, Platzman I, Spatz JP.
PMID: 32912650
Trends Biotechnol. 2021 May;39(5):445-459. doi: 10.1016/j.tibtech.2020.08.002. Epub 2020 Sep 07.

Creating a magic bullet that can selectively kill cancer cells while sparing nearby healthy cells remains one of the most ambitious objectives in pharmacology. Nanomedicine, which relies on the use of nanotechnologies to fight disease, was envisaged to fulfill...

Cite
Lussier F, Staufer O, Platzman I, et al. Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?. Trends Biotechnol. 2020;39(5):445-459doi: 10.1016/j.tibtech.2020.08.002.
Lussier, F., Staufer, O., Platzman, I., & Spatz, J. P. (2021). Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?. Trends in biotechnology, 39(5), 445-459. https://doi.org/10.1016/j.tibtech.2020.08.002
Lussier, Felix, et al. "Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?." Trends in biotechnology vol. 39,5 (2021): 445-459. doi: https://doi.org/10.1016/j.tibtech.2020.08.002
Lussier F, Staufer O, Platzman I, Spatz JP. Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?. Trends Biotechnol. 2021 May;39(5):445-459. doi: 10.1016/j.tibtech.2020.08.002. Epub 2020 Sep 07. PMID: 32912650.
Copy Download .nbib Format: NLM
[Tackle Tough Questions of DDS].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Arima H, Kawakami S.
PMID: 32378659
Yakugaku Zasshi. 2020;140(5):609-610. doi: 10.1248/yakushi.19-00218-F.

No abstract available.

Cite
Arima H, Kawakami S. [Tackle Tough Questions of DDS]. Yakugaku Zasshi. 2020;140(5):609-610doi: 10.1248/yakushi.19-00218-F.
Arima, H., & Kawakami, S. (2020). [Tackle Tough Questions of DDS]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 140(5), 609-610. https://doi.org/10.1248/yakushi.19-00218-F
Arima, Hidetoshi, and Kawakami, Shigeru. "[Tackle Tough Questions of DDS]." Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan vol. 140,5 (2020): 609-610. doi: https://doi.org/10.1248/yakushi.19-00218-F
Arima H, Kawakami S. [Tackle Tough Questions of DDS]. Yakugaku Zasshi. 2020;140(5):609-610. doi: 10.1248/yakushi.19-00218-F. Japanese. PMID: 32378659.
Copy Download .nbib Format: NLM
Theranostic nanomedicine for cancer.

Nanomedicine (London, England)

Sumer B, Gao J.
PMID: 18373419
Nanomedicine (Lond). 2008 Apr;3(2):137-40. doi: 10.2217/17435889.3.2.137.

No abstract available.

Cite
Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomedicine (Lond). 2008;3(2):137-40doi: 10.2217/17435889.3.2.137.
Sumer, B., & Gao, J. (2008). Theranostic nanomedicine for cancer. Nanomedicine (London, England), 3(2), 137-40. https://doi.org/10.2217/17435889.3.2.137
Sumer, Baran, and Gao, Jinming. "Theranostic nanomedicine for cancer." Nanomedicine (London, England) vol. 3,2 (2008): 137-40. doi: https://doi.org/10.2217/17435889.3.2.137
Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomedicine (Lond). 2008 Apr;3(2):137-40. doi: 10.2217/17435889.3.2.137. PMID: 18373419.
Copy Download .nbib Format: NLM
Drug eluting coronary artery stents.

Current drug delivery

Hirlekar R, Patel M, Jain S, Kadam V.
PMID: 20973760
Curr Drug Deliv. 2010 Dec;7(5):421-7. doi: 10.2174/156720110793566281.

Atherosclerosis is the primary cause of coronary heart disease, which is characterized by a narrowing (stenosis) of the arteries that supply blood to tissues of the heart. Over the past decade, the use of "Bare metallic stents" during Percutaneous...

Cite
Hirlekar R, Patel M, Jain S, et al. Drug eluting coronary artery stents. Curr Drug Deliv. 2010;7(5):421-7doi: 10.2174/156720110793566281.
Hirlekar, R., Patel, M., Jain, S., & Kadam, V. (2010). Drug eluting coronary artery stents. Current drug delivery, 7(5), 421-7. https://doi.org/10.2174/156720110793566281
Hirlekar, Rajashree, et al. "Drug eluting coronary artery stents." Current drug delivery vol. 7,5 (2010): 421-7. doi: https://doi.org/10.2174/156720110793566281
Hirlekar R, Patel M, Jain S, Kadam V. Drug eluting coronary artery stents. Curr Drug Deliv. 2010 Dec;7(5):421-7. doi: 10.2174/156720110793566281. PMID: 20973760.
Copy Download .nbib Format: NLM
Clinical developments in drug delivery nanotechnology.

Advanced drug delivery reviews

Forrest ML, Kwon GS.
PMID: 18358557
Adv Drug Deliv Rev. 2008 May 22;60(8):861-2. doi: 10.1016/j.addr.2008.02.013. Epub 2008 Mar 05.

No abstract available.

Cite
Forrest ML, Kwon GS. Clinical developments in drug delivery nanotechnology. Adv Drug Deliv Rev. 2008;60(8):861-2doi: 10.1016/j.addr.2008.02.013.
Forrest, M. L., & Kwon, G. S. (2008). Clinical developments in drug delivery nanotechnology. Advanced drug delivery reviews, 60(8), 861-2. https://doi.org/10.1016/j.addr.2008.02.013
Forrest, M Laird, and Kwon, Glen S. "Clinical developments in drug delivery nanotechnology." Advanced drug delivery reviews vol. 60,8 (2008): 861-2. doi: https://doi.org/10.1016/j.addr.2008.02.013
Forrest ML, Kwon GS. Clinical developments in drug delivery nanotechnology. Adv Drug Deliv Rev. 2008 May 22;60(8):861-2. doi: 10.1016/j.addr.2008.02.013. Epub 2008 Mar 05. PMID: 18358557.
Copy Download .nbib Format: NLM
Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA.

IDrugs : the investigational drugs journal

Lee RJ.
PMID: 18240093
IDrugs. 2008 Feb;11(2):101-4.

No abstract available.

Cite
Lee RJ. Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA. IDrugs. 2008;11(2):101-4
Lee, R. J. (2008). Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA. IDrugs : the investigational drugs journal, 11(2), 101-4.
Lee, Robert J. "Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA." IDrugs : the investigational drugs journal vol. 11,2 (2008): 101-4.
Lee RJ. Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA. IDrugs. 2008 Feb;11(2):101-4. PMID: 18240093.
Copy Download .nbib Format: NLM
From structures to functions: insights into exosomes as promising drug delivery vehicles.

Biomaterials science

Ren J, He W, Zheng L, Duan H.
PMID: 26977477
Biomater Sci. 2016 May 24;4(6):910-21. doi: 10.1039/c5bm00583c.

Exosomes are small membrane vesicles secreted by most cell types, and appear ubiquitously in cell culture supernatants and body fluids. Increasing evidence supports that exosomes play important roles in intercellular communication, both locally and systemically, by transporting their contents...

Cite
Ren J, He W, Zheng L, et al. From structures to functions: insights into exosomes as promising drug delivery vehicles. Biomater Sci. 2016;4(6):910-21doi: 10.1039/c5bm00583c.
Ren, J., He, W., Zheng, L., & Duan, H. (2016). From structures to functions: insights into exosomes as promising drug delivery vehicles. Biomaterials science, 4(6), 910-21. https://doi.org/10.1039/c5bm00583c
Ren, Jinghua, et al. "From structures to functions: insights into exosomes as promising drug delivery vehicles." Biomaterials science vol. 4,6 (2016): 910-21. doi: https://doi.org/10.1039/c5bm00583c
Ren J, He W, Zheng L, Duan H. From structures to functions: insights into exosomes as promising drug delivery vehicles. Biomater Sci. 2016 May 24;4(6):910-21. doi: 10.1039/c5bm00583c. PMID: 26977477.
Copy Download .nbib Format: NLM
Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.

Nanomedicine (London, England)

Muthu MS, Mei L, Feng SS.
PMID: 25204816
Nanomedicine (Lond). 2014 Jul;9(9):1277-80. doi: 10.2217/nnm.14.83.

No abstract available.

Cite
Muthu MS, Mei L, Feng SS. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy. Nanomedicine (Lond). 2014;9(9):1277-80doi: 10.2217/nnm.14.83.
Muthu, M. S., Mei, L., & Feng, S. S. (2014). Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy. Nanomedicine (London, England), 9(9), 1277-80. https://doi.org/10.2217/nnm.14.83
Muthu, Madaswamy S, et al. "Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy." Nanomedicine (London, England) vol. 9,9 (2014): 1277-80. doi: https://doi.org/10.2217/nnm.14.83
Muthu MS, Mei L, Feng SS. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy. Nanomedicine (Lond). 2014 Jul;9(9):1277-80. doi: 10.2217/nnm.14.83. PMID: 25204816.
Copy Download .nbib Format: NLM
Nanotech approaches to drug delivery and imaging.

Drug discovery today

Sahoo SK, Labhasetwar V.
PMID: 14678737
Drug Discov Today. 2003 Dec 15;8(24):1112-20. doi: 10.1016/s1359-6446(03)02903-9.

Nanotechnology, a multidisciplinary scientific undertaking, involves creation and utilization of materials, devices or systems on the nanometer scale. The field of nanotechnology is currently undergoing explosive development on many fronts. The technology is expected to create innovations and play...

Cite
Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today. 2003;8(24):1112-20doi: 10.1016/s1359-6446(03)02903-9.
Sahoo, S. K., & Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging. Drug discovery today, 8(24), 1112-20. https://doi.org/10.1016/s1359-6446(03)02903-9
Sahoo, Sanjeeb K, and Labhasetwar, Vinod. "Nanotech approaches to drug delivery and imaging." Drug discovery today vol. 8,24 (2003): 1112-20. doi: https://doi.org/10.1016/s1359-6446(03)02903-9
Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today. 2003 Dec 15;8(24):1112-20. doi: 10.1016/s1359-6446(03)02903-9. PMID: 14678737.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries